Perspective on animal models: Chronic intracellular infections

Clinical Infectious Diseases

Volumn 33, Issue SUPPL. 3, 2001, Pages

  Young, L S ^a   Bermudez, L E ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4.3.0]NON 8 YL) 6 FLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMIKACIN; ANTIBIOTIC AGENT; AZAQUINONE; AZITHROMYCIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; HMR 3004; MEFLOQUINE; MOXIFLOXACIN; PAROMOMYCIN; RIFABUTIN; RIFALAZIL; STREPTOMYCIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; CELL COMPARTMENTALIZATION; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; INFECTION; INFLAMMATORY CELL; LYMPHOCYTE COUNT; MOUSE; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; STRAIN DIFFERENCE;

ANIMALS; ANTITUBERCULAR AGENTS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MEFLOQUINE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PREDICTIVE VALUE OF TESTS;

EID: 0035884749     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321851     Document Type: Conference Paper

References (32)

1. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients
2. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
3. Experimental infections with Mycobacterium intracellulare
4. Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex
5. Determination of in vitro susceptibility, of Mycobacterium avium complex isolates to antimycobacterial agents by various methods
6. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex
7. In vitro and in vivo activities of clarithromycin against Mycobacterium avium
8. Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice
9. Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice
10. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice
11. Activities of Bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice
12. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin
13. Activities of ABT773, HMR3647 and linezolid against Mycobacterium avium in vitro and in vivo
14. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects
15. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex
16. Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: Concepts regarding acquisition and pathogenesis
17. Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice
18. Central nervous system infections with nontuberculous mycobacteria
19. An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract
20. Mycobacterium avium resists exposure to the acidic conditions of the stomach
21. Mycobacterium avium infection of gut mucosa in mice associated with late inflammatory response and intestinal cell necrosis
22. Nontuberculous mycobacterial meningitis: Report of two cases and review
23. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
24. Acquired resistance to mycobacterial infections
25. Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice
26. Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine
27. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection
28. The value of animal models for study of infection due to atypical mycobacteria
29. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses
30. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection
31. Susceptibility of immunocompetent beige and nude mice to Mycobacterium avium infection and response to clarithromycin